Edition:
United States

Sorrento Tech Inc (ROKA.OQ)

ROKA.OQ on NASDAQ Stock Exchange Global Market

0.94USD
3:59pm EST
Change (% chg)

$0.00 (+0.43%)
Prev Close
$0.94
Open
$0.94
Day's High
$0.97
Day's Low
$0.93
Volume
4,625
Avg. Vol
172,760
52-wk High
$6.20
52-wk Low
$0.66

Latest Key Developments (Source: Significant Developments)

Orbimed Advisors cuts stake in Roka Bioscience to 10.24 pct - SEC filing
Thursday, 5 Oct 2017 03:49pm EDT 

Oct 5 (Reuters) - Roka Bioscience Inc ::Orbimed Advisors LLC cuts stake in Roka Bioscience to 10.24 percent as of Oct 3 from a stake of 13.86 percent as of Sept 28 - SEC filing.  Full Article

Roka Bioscience says it entered into fourth amendment to loan and security agreement - SEC Filing​
Tuesday, 19 Sep 2017 04:18pm EDT 

Sept 19 (Reuters) - Roka Bioscience Inc :Roka Bioscience says ‍on Sept 19, 2017, Roka Bioscience entered into fourth amendment to loan and security agreement - SEC Filing​.Roka Bioscience - ‍As per amendment, co repaid in full outstanding balance of $4 million under its term loan with Comerica​.  Full Article

Roka Bioscience agrees to sell its assets to subsidiary of Institute for Environmental Health
Thursday, 17 Aug 2017 08:30am EDT 

Aug 17 (Reuters) - Roka Bioscience Inc :Roka Bioscience, Inc. agrees to sell its assets to subsidiary of Institute for Environmental Health, Inc..Roka Bioscience Inc - Deal for ‍$17.5 million​.Roka Bioscience Inc - ‍As part of transaction, Roka Bioscience will be required to make a $2.5 million milestone payment pursuant to its license agreement​.Roka Bioscience - ‍Entered into asset purchase agreement with rokabio inc for sale of substantially all of assets of co in an all-cash transaction​.Says ‍if co does not successfully complete transactions, co will have limited options for financing its ongoing​.Says if co does not successfully complete transactions, co will likely cease operations or file for bankruptcy protection​.  Full Article

Roka Bioscience Inc files for non-timely 10-Q
Monday, 14 Aug 2017 05:49pm EDT 

Aug 14 (Reuters) - Roka Bioscience Inc ::Roka Bioscience Inc files for non-timely 10-Q .  Full Article

Tamim Shansab reports 5.4 pct passive stake in Roka Bioscience
Thursday, 27 Jul 2017 03:25pm EDT 

July 27 (Reuters) - Roka Bioscience Inc :Tamim Shansab reports 5.4 percent passive stake in Roka Bioscience Inc as of July 24 - sec filing.  Full Article

Roka Bioscience announces agreement with PURE Bioscience
Monday, 10 Jul 2017 08:15am EDT 

July 10 (Reuters) - Roka Bioscience Inc :Roka Bioscience, Inc announces co-marketing and supply agreement with PURE Bioscience.Roka Bioscience - ‍entered into a two year nonexclusive supply agreement with PURE Bioscience.Agreement ‍to market PURE's line of antimicrobial disinfecting and sanitizing processing aids to food industry​.  Full Article

Roka Bioscience Q1 loss per share $1.53
Thursday, 11 May 2017 04:01pm EDT 

May 11 (Reuters) - Roka Bioscience Inc :Roka Bioscience reports first quarter 2017 financial results.Q1 loss per share $1.53.Q1 revenue $2.0 million versus $1.6 million.  Full Article

Roka Bioscience reports Q4 loss per share of $3.72
Thursday, 9 Mar 2017 04:05pm EST 

Roka Bioscience Inc : Roka Bioscience reports fourth quarter and full year 2016 financial results . Q4 revenue $1.9 million versus $1.5 million .Says Q4 loss earnings per share $3.72.  Full Article

Roka Bioscience reports Q3 loss per share $5.39
Monday, 7 Nov 2016 04:01pm EST 

Roka Bioscience Inc : Roka bioscience reports third quarter 2016 financial results . Q3 loss per share $5.39 .Says Q3 revenue $1.9 million.  Full Article

Roka Bioscience files for public offering of up to 62.8 mln shares of Co's common stock
Friday, 7 Oct 2016 05:02pm EDT 

Roka Bioscience Inc : Files for public offering of up to 62.8 million shares of Co's common stock by selling stockholders - SEC filing .Co will not receive any cash proceeds from the sale of any of shares of common stock by the selling stockholders..  Full Article

BRIEF-Edward Painter dissolves share stake in Roka Bioscience

* Edward Painter, CEO of A2A Pharmaceuticals, dissolves share stake in Roka Bioscience Inc as of Oct 20 - SEC filing Source text: (http://bit.ly/2ladEo7) Further company coverage: